Li H - Search Results

1

IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Li R, Wei F, Yu J, Li H, Ren X, Hao X. Li R, et al. Among authors: li h. Cancer Biol Ther. 2009 Jul;8(14):1402-8. doi: 10.4161/cbt.8.14.8882. Epub 2009 Jul 30. Cancer Biol Ther. 2009. PMID: 19597340 Free article.

2

Immunoactivative role of indoleamine 2,3‑dioxygenase in gastric cancer cells in vitro.

Zhang R, Li H, Yu J, Zhao J, Wang X, Wang G, Yao Z, Wei F, Xue Q, Ren X. Zhang R, et al. Among authors: li h. Mol Med Rep. 2011 Jan-Feb;4(1):169-73. doi: 10.3892/mmr.2010.398. Epub 2010 Nov 30. Mol Med Rep. 2011. PMID: 21461581

3

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.

Sun J, Yu J, Li H, Yang L, Wei F, Yu W, Liu J, Ren X. Sun J, et al. Among authors: li h. J Exp Clin Cancer Res. 2011 Sep 14;30(1):82. doi: 10.1186/1756-9966-30-82. J Exp Clin Cancer Res. 2011. PMID: 21917155 Free PMC article.

4

Fibroblast activation protein: A potential therapeutic target in cancer.

Liu R, Li H, Liu L, Yu J, Ren X. Liu R, et al. Among authors: li h. Cancer Biol Ther. 2012 Feb 1;13(3):123-9. doi: 10.4161/cbt.13.3.18696. Epub 2012 Feb 1. Cancer Biol Ther. 2012. PMID: 22236832 Free article. Review.

5

IDO⁺ DCs and signalling pathways.

Wang Y, Yang BH, Li H, Cao S, Ren XB, Yu JP. Wang Y, et al. Among authors: li h. Curr Cancer Drug Targets. 2013 Mar;13(3):278-88. doi: 10.2174/15680096113139990073. Curr Cancer Drug Targets. 2013. PMID: 23369095 Review.

6

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.

Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X. Yu J, et al. Among authors: li h. J Immunol. 2013 Apr 1;190(7):3783-97. doi: 10.4049/jimmunol.1201449. Epub 2013 Feb 25. J Immunol. 2013. PMID: 23440412

7

Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.

Hao X, Shao Y, Ren X, Liu H, Xu Q, Li H, Zhang P, An X, Ren B. Hao X, et al. Among authors: li h. J Cancer Res Clin Oncol. 2002 Sep;128(9):507-15. doi: 10.1007/s00432-002-0358-x. Epub 2002 Aug 21. J Cancer Res Clin Oncol. 2002. PMID: 12242516

8

[Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].

Li H, Ren XB, Zhang P, An XM, Liu H, Hao XS. Li H, et al. Zhonghua Yi Xue Za Zhi. 2005 Nov 23;85(44):3134-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16405818 Chinese.

9

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.

Li H, Yu JP, Cao S, Wei F, Zhang P, An XM, Huang ZT, Ren XB. Li H, et al. J Clin Immunol. 2007 May;27(3):317-26. doi: 10.1007/s10875-007-9076-0. Epub 2007 Apr 28. J Clin Immunol. 2007. PMID: 17468835

10

Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment.

Ren XB, Yu JP, Cao S, Ren BZ, Li H, Liu H, Min WP, Hao XS. Ren XB, et al. Among authors: li h. Cancer Biother Radiopharm. 2007 Apr;22(2):223-34. doi: 10.1089/cbr.2007.334. Cancer Biother Radiopharm. 2007. PMID: 17600469 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122,302 results

Search Page

Filters